Rascol Olivier, Goetz Christopher, Koller William, Poewe Werner, Sampaio Cristina
Clinical Investigation Centre and the Department of Clinical Pharmacology, INSERM U 455, Toulouse University Hospital, 31073 Toulouse Cedex, France.
Lancet. 2002 May 4;359(9317):1589-98. doi: 10.1016/S0140-6736(02)08520-3.
We did a systematic review, with a uniform method of assessment of efficacy and safety, to assess the different interventions available for the management of Parkinson's disease (drugs, surgical interventions, and physical treatments) with respect to the following indications: prevention of disease progression, symptomatic treatment of motor features (parkinsonism), symptomatic control of motor complications, prevention of motor complications, and symptomatic treatment of non-motor features. Our aim was not to define practice guidelines, but rather to improve clinicians' knowledge of the presently available published clinical evidence, based mainly on randomised controlled trials. We hope that our review will help doctors to incorporate this background into their own decision-making strategy to make appropriate choices with respect to the treatment of individual patients with Parkinson's disease.
我们进行了一项系统评价,采用统一的疗效和安全性评估方法,以评估针对帕金森病管理的不同干预措施(药物、手术干预和物理治疗)在以下指征方面的效果:预防疾病进展、运动症状(帕金森症)的对症治疗、运动并发症的对症控制、预防运动并发症以及非运动症状的对症治疗。我们的目的不是制定实践指南,而是主要基于随机对照试验,提高临床医生对目前已发表的临床证据的了解。我们希望我们的评价将帮助医生将这一背景纳入他们自己的决策策略,以便在治疗帕金森病个体患者时做出适当选择。